Atherosclerosis is one of the most significant yet unresolved problems in patients on regular Hemodialysis (HD) with major impact on morbidity and mortality of patients with end-stage renal disease (ESRD).
No takes yet. Share an insight, caveat, or question.
Ioannis Griveas (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: